201 related articles for article (PubMed ID: 9892529)
1. Mycobacterium kansasii and human immunodeficiency virus co-infection in London.
Klein JL; Corbett EL; Slade PM; Miller RF; Coker RJ
J Infect; 1998 Nov; 37(3):252-9. PubMed ID: 9892529
[TBL] [Abstract][Full Text] [Related]
2. Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1.
Witzig RS; Fazal BA; Mera RM; Mushatt DM; Dejace PM; Greer DL; Hyslop NE
Clin Infect Dis; 1995 Jul; 21(1):77-85. PubMed ID: 7578764
[TBL] [Abstract][Full Text] [Related]
3. Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease.
Moon SM; Choe J; Jhun BW; Jeon K; Kwon OJ; Huh HJ; Lee NY; Daley CL; Koh WJ
Respir Med; 2019 Mar; 148():37-42. PubMed ID: 30827472
[TBL] [Abstract][Full Text] [Related]
4. Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study.
Bloch KC; Zwerling L; Pletcher MJ; Hahn JA; Gerberding JL; Ostroff SM; Vugia DJ; Reingold AL
Ann Intern Med; 1998 Nov; 129(9):698-704. PubMed ID: 9841601
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium kansasii septicaemia in an AIDS patient complicated by acute respiratory distress syndrome and acute liver failure.
Shaaban H; Layne T; Sensakovic JW; Boghossian J
Int J STD AIDS; 2014 Feb; 25(2):152-4. PubMed ID: 23970643
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium kansasii.
Johnston JC; Chiang L; Elwood K
Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28185617
[TBL] [Abstract][Full Text] [Related]
7. Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London.
Davies BS; Roberts CH; Kaul S; Klein JL; Milburn HJ
Scand J Infect Dis; 2012 Nov; 44(11):815-9. PubMed ID: 23078529
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium kansasii among patients infected with human immunodeficiency virus in Kansas City. Kansas City AIDS Research Consortium.
Bamberger DM; Driks MR; Gupta MR; O'Connor MC; Jost PM; Neihart RE; McKinsey DS; Moore LA
Clin Infect Dis; 1994 Mar; 18(3):395-400. PubMed ID: 8011822
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection.
Levine B; Chaisson RE
Ann Intern Med; 1991 May; 114(10):861-8. PubMed ID: 1673053
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and epidemiological study of disease caused by Mycobacterium kansasii in the metropolitan area of Bilbao, Spain].
Leal Arranz MV; Gaafar A; Unzaga Barañano MJ; Crespo Notario JA; Cisterna Cáncer R; García Cebrián F
Arch Bronconeumol; 2005 Apr; 41(4):189-96. PubMed ID: 15826528
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium kansasii pericarditis as a presentation of AIDS.
Pintado V; Fortún J; Casado JL; Gómez-Mampaso E
Infection; 2001; 29(1):48-50. PubMed ID: 11261760
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium kansasii infection in patients infected with the human immunodeficiency virus.
Pintado V; Gómez-Mampaso E; Martín-Dávila P; Cobo J; Navas E; Quereda C; Fortún J; Guerrero A
Eur J Clin Microbiol Infect Dis; 1999 Aug; 18(8):582-6. PubMed ID: 10517196
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium kansasii: its presentation, treatment and outcome in HIV infected patients.
Rooney G; Nelson MR; Gazzard B
J Clin Pathol; 1996 Oct; 49(10):821-3. PubMed ID: 8943748
[TBL] [Abstract][Full Text] [Related]
14. Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study.
Rawson TM; Abbara A; Kranzer K; Ritchie A; Milburn J; Brown T; Adeboyeku D; Buckley J; Davidson RN; Berry M; Kon OM; John L
Respir Med; 2016 Nov; 120():101-108. PubMed ID: 27817806
[TBL] [Abstract][Full Text] [Related]
15. Double lung transplantation in an HIV-positive patient with Mycobacterium kansasii infection.
Ambaraghassi G; Ferraro P; Poirier C; Rouleau D; Fortin C
Transpl Infect Dis; 2019 Feb; 21(1):e12999. PubMed ID: 30203904
[TBL] [Abstract][Full Text] [Related]
16. Mycobacterium kansasii pulmonary diseases in Korea.
Yim JJ; Park YK; Lew WJ; Bai GH; Han SK; Shim YS
J Korean Med Sci; 2005 Dec; 20(6):957-60. PubMed ID: 16361804
[TBL] [Abstract][Full Text] [Related]
17. Mediastinal and Disseminated Mycobacterium kansasii Disease in GATA2 Deficiency.
Lovell JP; Zerbe CS; Olivier KN; Claypool RJ; Frein C; Anderson VL; Freeman AF; Holland SM
Ann Am Thorac Soc; 2016 Dec; 13(12):2169-2173. PubMed ID: 27607353
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.
Shitrit D; Baum GL; Priess R; Lavy A; Shitrit AB; Raz M; Shlomi D; Daniele B; Kramer MR
Chest; 2006 Mar; 129(3):771-6. PubMed ID: 16537880
[TBL] [Abstract][Full Text] [Related]
19. Detailed analysis of the radiographic presentation of Mycobacterium kansasii lung disease in patients with HIV infection.
Cattamanchi A; Nahid P; Marras TK; Gotway MB; Lee TJ; Gonzalez LC; Morris A; Webb WR; Osmond DH; Daley CL
Chest; 2008 Apr; 133(4):875-80. PubMed ID: 18263685
[TBL] [Abstract][Full Text] [Related]
20. Temporal interferon-gamma release response to Mycobacterium kansasii infection in an anorexia nervosa patient.
Cosson MA; Bertrand JB; Martin C; Veziris N; Picard C; Goulvestre C; Coignard S; Benoit JP; Silvera S; Moro MR; Poyart C; Morand PC
J Med Microbiol; 2012 Nov; 61(Pt 11):1617-1620. PubMed ID: 22859583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
